Olfr488, belonging to the G protein-coupled receptor (GPCR) family, plays a pivotal role in olfactory sensory perception by serving as a chemosensory receptor. Positioned on the cell membrane of olfactory sensory neurons, Olfr488 is tasked with the detection and transduction of specific odorant molecules, initiating signaling cascades that contribute to the complex landscape of olfactory sensation. The receptor's selectivity in recognizing distinct chemical stimuli highlights its significance in shaping an organism's olfactory experience, influencing behavioral responses based on environmental cues.
The inhibition of Olfr488 involves a sophisticated interplay of chemical modulators, each meticulously designed to target specific components within intracellular signaling pathways associated with this GPCR. These inhibitors act through diverse mechanisms, finely tuned to disrupt crucial cellular processes. Compounds impacting the MAPK pathway, for instance, exert their influence downstream, modulating elements such as SPRY4, leading to indirect inhibition of Olfr488. Pertussis Toxin interferes with G protein subunits, disrupting GPCR signaling and contributing to Olfr488 inhibition. Additionally, molecules altering intracellular calcium dynamics, like Thapsigargin and Thioridazine, influence calmodulin-associated cascades, indirectly impacting Olfr488 activity. Inhibition through the PI3K-AKT pathway, facilitated by compounds such as Wortmannin and LY294002, showcases the intricate nature of signaling modulation, ultimately influencing Olfr488 function. The diversity in mechanisms underscores the complexity of GPCR inhibition, offering valuable insights into potential avenues for further research in understanding olfactory transduction processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multikinase inhibitor targeting RAF and VEGFR, indirectly impacting Olfr488 by disrupting downstream signaling cascades. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits Gαi proteins, affecting GPCR signaling and leading to indirect inhibition of Olfr488. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress by inhibiting SERCA, triggering unfolded protein response (UPR) and influencing Olfr488 activity indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr488 inhibition indirectly. | ||||||
OG-L002 | 1357302-64-7 | sc-478221 | 5 mg | $270.00 | ||
Targets Rho kinase, modulating cytoskeletal dynamics and GPCR signaling, indirectly inhibiting Olfr488. | ||||||
Thioridazine | 50-52-2 | sc-473180 | 50 mg | $500.00 | ||
Alters intracellular calcium levels, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr488. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Selective p38 MAPK inhibitor impacting downstream effectors, contributing to Olfr488 inhibition through the MAPK pathway indirectly. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, disrupting downstream signaling pathways and contributing to Olfr488 inhibition indirectly. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Calmodulin kinase II (CaMKII) inhibitor, influencing calmodulin-associated cascades, leading to indirect inhibition of Olfr488. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor disrupting PI3K-AKT pathway, impacting downstream signaling and contributing to Olfr488 inhibition indirectly. | ||||||